JMP Securities initiated coverage on NovoCure Ltd. (NASDAQ: NVCR) with a Market Outperform rating and a price target of $43.00.

For an analyst ratings summary and ratings history on NovoCure Ltd. click here. For more ratings news on NovoCure Ltd. click here.

Shares of NovoCure Ltd. closed at $20.58 yesterday.

New Coverage

JPMorgan Starts NovoCure Ltd. (NVCR) at OverweightOctober 27, 2015 8:11 AM Wedbush Starts NovoCure Ltd. (NVCR) at OutperformOctober 27, 2015 7:28 AM Novocure (NVCR) Reports Q3 Loss of $2.09/ShareOctober 26, 2015 4:14 PM Form 8-K Novocure Ltd For: Oct 26October 26, 2015 4:13 PM Novocure Reports Third Quarter 2015 Operating and Financial ResultsOctober 26, 2015 4:05 PM